Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,265 | 89 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Corium, LLC | $145.49 | 14 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $130.00 | 7 | $0 (2024) |
| Alkermes, Inc. | $124.13 | 9 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $116.91 | 4 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $89.15 | 6 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $83.46 | 6 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $70.80 | 12 | $0 (2022) |
| HARMONY BIOSCIENCES LLC | $67.54 | 3 | $0 (2024) |
| Neuronetics, Inc. | $63.86 | 2 | $0 (2024) |
| Tris Pharma Inc | $45.60 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $406.73 | 22 | Supernus Pharmaceuticals, Inc. ($101.58) |
| 2023 | $183.37 | 15 | Corium, LLC ($74.52) |
| 2022 | $313.34 | 19 | Teva Pharmaceuticals USA, Inc. ($76.72) |
| 2021 | $65.72 | 5 | Eisai Inc. ($15.44) |
| 2020 | $39.70 | 3 | Eisai Inc. ($14.35) |
| 2019 | $115.40 | 8 | Alkermes, Inc. ($59.91) |
| 2018 | $39.46 | 3 | Janssen Pharmaceuticals, Inc ($28.75) |
| 2017 | $101.41 | 14 | Sunovion Pharmaceuticals Inc. ($43.40) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/18/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: OUD | ||||||
| 09/04/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: Narcoplepsy | ||||||
| 08/27/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $31.93 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/27/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $31.93 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/14/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/16/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $36.39 | General |
| Category: Narcoplepsy | ||||||
| 07/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/26/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 06/24/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/06/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Neuropsychiatry | ||||||
| 05/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.85 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 03/07/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: ADHD | ||||||
| 02/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 01/23/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 01/09/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/07/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/07/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 651 | 1,666 | $421,205 | $95,649 |
| 2022 | 8 | 617 | 1,475 | $386,792 | $90,606 |
| 2021 | 12 | 710 | 1,753 | $416,435 | $116,468 |
| 2020 | 12 | 680 | 1,716 | $372,766 | $93,298 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 256 | 766 | $278,633 | $63,430 | 22.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 184 | 500 | $109,180 | $25,471 | 23.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 14 | 14 | $8,592 | $2,017 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 15 | $7,697 | $1,479 | 19.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 62 | 153 | $4,217 | $1,285 | 30.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 56 | 73 | $3,692 | $694.96 | 18.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 15 | 88 | $4,820 | $669.68 | 13.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 38 | 39 | $3,889 | $511.68 | 13.2% |
| 84450 | Liver enzyme (sgot), level | Office | 2023 | 13 | 18 | $485.82 | $91.44 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 283 | 879 | $310,674 | $74,154 | 23.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 102 | 226 | $48,409 | $11,521 | 23.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 17 | 18 | $10,924 | $2,530 | 23.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 58 | 72 | $3,641 | $691.04 | 19.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 49 | 49 | $4,886 | $647.40 | 13.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 21 | 70 | $3,834 | $536.70 | 14.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 70 | 138 | $3,803 | $409.14 | 10.8% |
| 84450 | Liver enzyme (sgot), level | Office | 2022 | 17 | 23 | $620.77 | $117.69 | 19.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 286 | 923 | $296,560 | $86,684 | 29.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 130 | 347 | $73,599 | $18,905 | 25.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 30 | $12,947 | $4,227 | 32.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 21 | 21 | $9,834 | $2,999 | 30.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 64 | 76 | $3,843 | $737.96 | 19.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 20 | 83 | $4,546 | $644.91 | 14.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 13 | $2,880 | $589.76 | 20.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 39 | 39 | $3,889 | $522.21 | 13.4% |
About Dr. Edward Sathoff, MD
Dr. Edward Sathoff, MD is a Psychiatry healthcare provider based in Mankato, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093794950.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Sathoff, MD has received a total of $1,265 in payments from pharmaceutical and medical device companies, with $406.73 received in 2024. These payments were reported across 89 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,265).
As a Medicare-enrolled provider, Sathoff has provided services to 2,658 Medicare beneficiaries, totaling 6,610 services with total Medicare billing of $396,022. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Mankato, MN
- Active Since 01/10/2006
- Last Updated 07/15/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1093794950
Products in Payments
- Azstarys (Drug) $115.97
- Qelbree (Drug) $101.58
- NUPLAZID (Drug) $89.15
- ARISTADA (Drug) $79.19
- LATUDA (Drug) $70.80
- WAKIX (Drug) $67.54
- NEUROSTAR TMS THERAPY SYSTEM (Device) $63.86
- JORNAY PM (Drug) $57.57
- INVEGA SUSTENNA (Drug) $41.39
- Dayvigo (Drug) $29.79
- QELBREE (Drug) $28.42
- VRAYLAR (Drug) $27.13
- TRINTELLIX (Drug) $26.39
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $25.89
- Aristada 441 mg (Drug) $25.80
- CAPLYTA (Drug) $25.78
- REXULTI (Drug) $25.53
- SUBLOCADE (Drug) $20.20
- UZEDY (Drug) $19.05
- FANAPT (Drug) $18.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Mankato
Dr. Danielle Magness-Wellmann, Do, DO
Psychiatry — Payments: $179,693
Dr. Michael Moeller, Md, MD
Psychiatry — Payments: $1,032
Robert Olson, Md, MD
Psychiatry — Payments: $1,003
Sreelatha Spieker, Md, MD
Psychiatry — Payments: $802.50
Veronica Radigan, M.d, M.D
Psychiatry — Payments: $510.47
Dr. Travis Hansen, M.d, M.D
Psychiatry — Payments: $341.71